Consultant Pharmacists: Roles, Responsibilities & Resources · 2020-01-29 · Consultant...

ConsultantPharmacists:Roles,Responsibilities&Resources

NicoleBrandt,PharmD,CGP,BCPP,FASCPDirectorofClinicalandEducationalProgramsPeterLamyCenteronDrugTherapyandAgingAssociateProfessor,GeriatricPharmacotherapy,UniversityofMarylandSchoolofPharmacy

Contactat:nbrandt@rx.umaryland.edu

JenniferL.Hardesty,PharmD,FASCPClinicalServicesManager,RemediSeniorCareContactat:jennifer.hardesty@remedirx.com

University of Maryland Baltimore

School of Pharmacy

Materialfromtoday’spresentationswillbepostedonline.

1

WhataretheRegulationsinMarylandsurroundingMedicationManagement?

Accessthemat:http://www.dsd.state.md.us/comar/

10/10.07.14.29.htm

This was reviewed in the morning sessions so please refer to those notes.

2

10.07.14.29MedicationManagementandAdministration

• ResidentswhoSelfAdministerMedications:– ALmanagermustensureassessmentiscompleteduponadmissionwhichstatestheyareabletoselfmedicate

– Quarterlyevaluationmustbecompletedbythedelegatingnursetoensurethattheyarestillsafetoselfmedicate

When patients are admitted into ALFs, how do we assess whether or not theyare capable of self-administration of medications? Who checks this?Nurses do. Download form for assessment online from Board of Nursingwebsite.

85% of patients in ALF need help with medications.

Medication self-administration decisions are considered a gray area due tomany reasons -including financial, social, safety and medical aspects. Manypatients do not want to lose their sense of autonomy. Still, many patients arereally not able to self administer due to tactile, memory or cognitive difficulties.Patients cannot self-administer some of their medications: it is either all ornothing.

3

MedicationReviewUponAdmission

• TheALmanagershallconsultwithin14daysofaresident’sadmissionwiththefollowingindividualswhocanconductamedicationreview:– PrimaryCarePhysician

– Certifiedregisterednursepractitioner

– Certifiedregisterednursemidwife

– Registerednurse,whomaybethedelegatingnurseor

– Licensedpharmacist.

It is good practice for ALFs to contact a team to conduct a medication reviewupon admission of a new resident. Transition stages between discharges andadmissions into ALFs are the most likely times for medication errors. Most ofthe problems arise from communication issues between the hospital and ALFstaff. In order to prevent readmissions and to stabilize care, it is also best toinvolve a pharmacist or team from the very beginning.

One of the major concerns is medication reconciliation and making sure allmedications are necessary and appropriate.

4

PurposeofthisReview• IstoreviewwiththeALmanagerordesignee:

– Aresident’scurrentmedicationprofile,includingallprescriptionandnonprescriptionmedicationsandfeedings

– Thepotentialthatcurrentmedicationshavetoactaschemicalrestraints

– Thepotentialforanyadversedruginteractions,includingpotentialsideeffectsfromthemedicationsand

– Anymedicationerrorsthathaveoccurredsinceadmission.

5

PharmacyReview

• TheALmanagershallarrangeforalicensedpharmacisttoconductanon‐sitereviewofphysicianprescriptions,physicianordersandresidentrecordsatleastevery6monthsforanyresidentreceiving9ormoremedicationswhichincludeoverthecounterandasneededmedications.

Poll of audience indicates that most sites would like the pharmacist to come inand review all patient charts. Other sites ask pharmacists to only reviewpatients with 9 medications or more, for financial reasons.

6

ThePharmacist’sReview

• Shallincludebutisnotlimitedto,whether:– ProgramisincompliancewithBoardofPharmacy’srequirementsforpackagingof

medications

– Eachresident’smedicationsareproperlystoredandmaintained

– Eachresidentreceivesthemedicationsthathavebeenspecificallyprescribedforthatresidentinthemannerthathasbeenordered.

– Basedonavailableinformation,thedesiredeffectivenessofeachmedicationisachieved,and,ifnot,thattheappropriateauthorizedprescriberissoinformed;

– Anyundesiredsideeffects,potentialandactualadversedrugreactions,andmedicationerrorsareidentifiedandreportedtotheappropriateauthorizedprescriber;

– Theresidenthasamedicalconditionasdocumentedintheresident'srecordsthatisnotcurrentlybeingtreatedbymedication;

– Thereisdrugusewithoutcurrentindicationintheresident'srecordsofamedicalconditionthatwarrantstheuseofthedrug;

Resources can be found at http://www.geri-ed.umaryland.edu/ . (MedicationManagement)There is a webinar post for families. The page also has a downloadable ALFmedication review checklist, which goes through COMAR regulations.

Among other things, the pharmacist makes sure schedule II drugs are doublelocked. He/she also reviews medication carts to make sure recalls and expiredmedications are properly disposed of.

All types of medications are included in the 9 medications qualification –including Rx, herbal, OTC, PRNs.

Common issues:- OTCs: always problematic because they are less likely to be reported (andcan, for example, result in Tylenol toxicity, drug-drug interactions…)- Monitoring: many adverse effects occur because of poor monitoring.Pharmacists can make a big impact by educating other health carepractitioners on monitoring of drugs.- Acquiring laboratory work is a tedious and time consuming task, but is vitalfor monitoring and for patient safety.- Clinical Relevance: when is it, for example, clinically relevant to report andact on drug-drug interactions?

The information from the pharmacist’s review should be provided to both theprescriber and the ALF manager.

7

ThePharmacist’sReviewcont

• Shallincludebutisnotlimitedto,whether:– Thereisdrugoverusethatiscausingsideeffectsasdocumentedintheresidentrecords;

– Currentmedicationselectionsresultininappropriatedrugdosage;

– Theresidentmaybeexperiencingdruginteractions;

– Theresidentisreceivingmedication,eitherprescribedorover‐the‐countermedications,aswellasherbalremediesthatcouldresultindrug‐drug,drug‐food,ordrug‐laboratorytestinteractions;

– Administrationtimesofmedicationneedtobemodifiedtoaddressdruginteractionsormealtimes,orboth;

– Theresidentrecordsneedtobereviewedtoassurethatperiodicdiagnosticmonitoringrequiredbycertainmedicationshavebeenperformed;and

– Theresident'smedicationregimensneedtobereviewedtodetermineifmorecost‐effectivemedicationsareavailabletotreatcurrentmedicalconditions

8

DocumentationandFollow‐up

• Thepharmacistshalldocumentthepharmacyreviewasrequiredunderthissectionineachresident'schartandthisdocumentationshallbereviewedevery6monthsaspartoftheassistedlivingprogram'squalityassuranceactivitiesasrequiredinRegulation.13ofthischapter.

• Thepersonconductingtheon‐sitereviewunder§ForIofthisregulationshallrecommendchanges,asappropriate,totheappropriateauthorizedprescriberandtheassistedlivingmanagerordesignee.

9

RolesandResponsibilities

10

1.PerformaMedicationRegimenReview(MRR)

• WhatisMRR?– “Thoroughevaluationofthemedicationregimenofaresident,withthegoalofpromotingpositiveoutcomesandminimizingadverseconsequencesassociatedwithmedications;Thereviewincludespreventing,identifying,reporting,andresolvingmedication‐relatedproblems(MRPs),medicationerrors,orotherirregularitiesandcollaboratingwithothersmembersoftheinterdisciplinaryteam.”

CentersforMedicareandMedicaidServices.StateOperationsManutal.AppendixPP:GuidancetoSurveyorsforLongTermcarefacilitiesRev.26Accessedatwww.cms.hhs.gov/manuals/downloads/som107_Appendicestoc.pdfwww.cms.hhs.gov/manuals/downloads/som107_Appendicestoc.pdf.onOctober16,2008.

2.ProvideOngoingEducationtoDirectCareStaff,Residentsand/ortheFamily

• Medicationmanagementisbasedinthecareprocessandincludes:– Recognitionoridentificationoftheproblem/need

– Assessment

– Diagnosis/causeidentification

– Management/treatment

– Monitoring

– Revisinginterventions• CentersforMedicareandMedicaidServices.StateOperationsManutal.AppendixPP:GuidancetoSurveyorsforLongTermcare

facilitiesRev.26,Accessedatwww.cms.hhs.gov/manuals/downloads/som107_Appendicestoc.pdfwww.cms.hhs.gov/manuals/downloads/som107_Appendicestoc.pdf.onOctober16,2008.

12

DiagnosticMonitoring• Physician Orders & Communication of Results

– Is there an existing physicians’ order for lab monitoring and if so, is itbeing followed?

– Ask for copies of lab reports and place in residents chart

• Monitoring for Common Medical Conditions andMedications

– Type II Diabetes– High Blood Pressure– Dementia

• Potentially Problematic Medications– Narrow Therapeutic Medications:

• Warfarin (Coumadin),• Digoxin,• Carbamazepine (Tegretol),• Lithium,• Theophylline,• Levothyroxine (Synthroid), &• Valproic Acid (Depakote) ……

13

3.AssistwithAssessingResident’sabilitytoSelfAdministerMedications

• Variousscreeningandassessmenttoolstoevaluatearesident’sabilitytoselfmedicate.

e.g.,MediCog:evaluatestheabilitytosetupapillbox• TwoPartScreen• Mini‐Cog:detectsclinicallysignificantcognitiveimpairment• MedicationTransferScreen(MTS):evaluatesskillsindecipheringprescriptionsandabilitytosequenceandlocate

AndersonK,JueSG,Madaras‐KellyKJ.IdentifyingPatientsatRiskforMedicationMismanagement:UsingCognitiveScreenstoPredictaPatient’sAccuracyinFillingaPillbox.ConsultPharm2008;June;23(6):259‐72

14

Medi‐CogMethod

This is a good tool to assess self-medication ability.

15

Resources

16

MedicationManagementinAssistedLivingFacilitieswebbasedseminar&Resources

• Intent of this webinar is to increase the knowledge ofhealthcare professionals, facilities and families to thecomplexity of medication management issues that exist inALFs.

• Interdisciplinary Faculty:– Nicole Brandt, PharmD (pharmacy),– Barbara Resnick, PhD, CRNP (nursing),– Richard Stefanacci, DO (medicine) and– Jacqueline Pinkowitz, M Ed. (consumer advocacy).

• Launched July 2009 & CEAL award recipient• The web page address is: http://geri-ed.umaryland.edu.

ThiswebinarisnowavailableattheMedicationManagementforOlderAdultswebsiteat,medmanagement.umaryland.edu.

17

WorkGroup

• UMSchoolofPharmacyisspearheadingamultifacetedapproachtoimprovingmedicationmanagementandultimatelycaretoresidentsinAssistedLivingthroughacollaborativeworkgroup:

• Workgroupmembers:– Pharmacy,NursingandMedicinefaculty– Representativesfromthe:

• BoardsofPharmacyandNursing,• OfficeofHealthcareQuality,• Lifespanand• GeriatricsandGerontologyEducationandResearchProgram.

Theintentofthisworkgroupistoeducatehealthcareprofessionals,ALFstaffaswellaspolicymakersontheissuesofmedicationmanagementinALFs.Inaddition,thegroupwillbeevaluatingtheimpactofthenewregulations,focusingonpharmacyissuesandtheroleofconsultantpharmacistsintermsofmedicationrelatedproblems,patientsafetyandcosts.

18

19

Resources

• Lifespan– www.lifespan‐network.org/

• AmericanSocietyofConsultantPharmacists– www.ascp.com– www.ascp.com/resources/settings/assistedliving/index.cfm

• CenterforExcellenceinAssistedLiving:– www.theceal.org

• ConsumerConsortiumonAssistedLiving– www.ccal.org

20

HelpfulWebsitesForInformationonAssistedLivingandGeriatrics

• AmericanMedicalDirector’sAssociation– www.amda.com

• AmericanAssociationofRetiredPersons– www.aarp.org

• NationalCenterforAssistedLiving– www.ncal.org

• TheAmericanGeriatricsSociety– www.americangeriatrics.org

• AssistedLivingInfo– www.assistedlivinginfo.com

• AssistedLivingFederationofAmerica– www.alfa.org

20

Resources

• MTMSandtheMillionDollarQuestion:HowWillALFResidentsBenefit?http://www.assistedlivingconsult.com/issues/01‐03/ALC1‐3_MTMS.pdf

• PrimerforMedicationManagement:WhatPractitionersNeedtoKnowhttp://www.theceal.org/downloads/CEAL_1183488426.pdf

21

CaseDiscussion

22

Case

• 91yroldmalewhoisnewtotheAssistedLivingFacility.Thereislimitedinformationonhispastmedicalhistoryandheisnotagoodhistorian.Hestateshelivedonfarmandreceivedlittlemedicalcareinthepast.Henotesheisnothappywithhismoveintothefacility.

• OneoftheconcernsfromthemedicalteamistheuseofhismedicationswithhisconcomitantHepatitisandimpairedliverfunction.

23

PastMedicalHistory&Labs

PastMedicalHistory:

• Dyslipidemia

• TypeIIDiabetesMellitus

• CoronaryArteryDisease

• h/oHepatitisC

• BenignProstaticHypertrophy

LabsonAdmission:

• AST:179

• ALT:103

• AlkPhos:185

• Alb:3

• HgA1C:7.9%

• HepCpositive

• BMP&CBC:WNL(Cr=1.0)

24

MedicationList

• Metformin500mg1tablettwicedaily• Glipizide10mg1tablettwicedaily• Lantus10unitsintheevening• Simvastatin40mgintheevening• Lisinopril10mginthemorning

Medication related issues:1)Type II DM: In light of his age as well as his hepatic dysfunction, I wouldrecommend stopping Metformin and Glipizid and just keep him on Lantus.Increase the Lantus dose to 12 units, monitor and then optimize further (this isa conservative increase based on limited BS when the two medications arestopped). In light of his age, we just want to maintain his HgA1C< 8% ifpossible. Both Metformin and Glipizide should be used cautiously in hepaticdysfunction.

2) Dyslipidemia: In light of his hepatic dysfunction, I would recommendstopping the statin.

3) Monitor his liver function quarterly. We may also want to monitor hisPT/INR.

4) Depression; May consider referring him to a psychiatric for a follow-up.

5) h/o BPH; The patient had been tried on various medications for BPH but didnot tolerate them. Not sure what the agents were though. Will defer to urologyfollow-up.

6) Health Maintenance; Consider starting an ASA 81mg daily.

Thank you for your consideration!

25

Whereisthispatientinthecontinuumofcare?

A. Primary&SecondaryPrevention

B. QOL/ReduceAcuteExacerbation

C. EOL/ComfortCare

A. Primary and secondary care in a 91 year old: more important to ask whatthe patient would like and what his/her family wants.

26

Whichofthefollowingmedication(s)wouldyouplantodiscontinue?

A. Metformin500mg1tablettwicedailyB. Glipizide10mg1tablettwicedailyC. Lantus10unitsintheeveningD. Simvastatin40mgintheeveningE. Lisinopril10mginthemorning

Ultimately, the patient was kept on Lantus 12 units in the evening andLisinopril 10mg in the morning. The rest were discontinued.

27

Howwouldyoumonitorthispatient?

A. CheckfingersticksthreetimesadayB. CheckHgA1CquarterlyC. Checklipidpanelsevery3monthsD. AlloftheAboveE. NoneoftheAbove

Stopping medications is just as important as starting medications and stoppingmonitoring labs is just as important as starting them.In the long run, the patient would not need finger sticks and HgA1c testingonce glucose stabilizes, and lipid panels will not be needed since Simvastatinwas stopped.

28

Nicole Brandt, PharmD, CGP, BCPP, FASCPAssociate Professor, Geriatric Pharmacotherapy-

University of Maryland School of Pharmacynbrandt@rx.umaryland.edu

29

TheUniversityofMaryland,SchoolofPharmacyhasbeenleadinganAssistedLivingFacilityWorkgroupmadeupofstakeholderssuchasfaculty,longtermcarepharmacists,BoardsofPharmacyandNursingrepresentation,GeriatricsandGerontologyEducationandResearchProgramaswellasOfficeofHealthcareQualitystafftoadvanceeducationandresearchregardingmedicationmanagementinALFs.TheUniversityofMaryland,

SchoolofPharmacyisinterestedincollectingdataonwhatpharmacistsarefindingwhentheyareconductingtheirmedicationreviews.Inaddition,astandardizedchecklisthasbeendevelopedwithaneducationalwebinartohelppharmacistsmeettheregulationsandprovideadequatedocumentation.Ifyouareinterestedinlearningmore,pleasefeel

tocontactDr.Brandtatnbrandt@rx.umaryland.eduaswellasvisitthehttp://geri‐ed.umaryland.edutohaveaccesstotheeducationaltoolsundertheMedication

Managementsection.

University of Maryland Baltimore

School of Pharmacy

Keepintouch=).Thankyou!

30